These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1740460)

  • 1. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.
    Ortel TL; Devore-Carter D; Quinn-Allen M; Kane WH
    J Biol Chem; 1992 Feb; 267(6):4189-98. PubMed ID: 1740460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.
    Ortel TL; Quinn-Allen MA; Charles LA; Devore-Carter D; Kane WH
    J Clin Invest; 1992 Dec; 90(6):2340-7. PubMed ID: 1281831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting region.
    Kane WH; Devore-Carter D; Ortel TL
    Biochemistry; 1990 Jul; 29(29):6762-8. PubMed ID: 2397212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Blood; 2008 Oct; 112(7):2795-802. PubMed ID: 18587009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis.
    Kim SW; Quinn-Allen MA; Camp JT; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
    Biochemistry; 2000 Feb; 39(8):1951-8. PubMed ID: 10684644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.
    Kim SW; Ortel TL; Quinn-Allen MA; Yoo L; Worfolk L; Zhai X; Lentz BR; Kane WH
    Biochemistry; 1999 Aug; 38(35):11448-54. PubMed ID: 10471296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex.
    Nicolaes GA; Villoutreix BO; Dahlbäck B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):89-100. PubMed ID: 10691103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
    Gerads I; Tans G; Yukelson LYa ; Zwaal RF; Rosing J
    Toxicon; 1992 Sep; 30(9):1065-79. PubMed ID: 1440644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.
    Gilbert GE; Novakovic VA; Kaufman RJ; Miao H; Pipe SW
    Blood; 2012 Aug; 120(9):1923-32. PubMed ID: 22613792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of factor VIII inhibitors to discrete regions of the factor VIII C2 domain disrupt phospholipid binding.
    Lewis DA; Moore KD; Ortel TL
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):361-8. PubMed ID: 12945878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine.
    Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
    Blood; 1990 May; 75(10):1999-2004. PubMed ID: 2110840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the MMRN1 binding region within the C2 domain of human factor V.
    Jeimy SB; Woram RA; Fuller N; Quinn-Allen MA; Nicolaes GA; Dahlbäck B; Kane WH; Hayward CP
    J Biol Chem; 2004 Dec; 279(49):51466-71. PubMed ID: 15452129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras.
    Ortel TL; Quinn-Allen MA; Keller FG; Peterson JA; Larocca D; Kane WH
    J Biol Chem; 1994 Jun; 269(22):15898-905. PubMed ID: 7515064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis.
    Saleh M; Peng W; Quinn-Allen MA; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
    Thromb Haemost; 2004 Jan; 91(1):16-27. PubMed ID: 14691564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the B domain for factor VIII and factor V expression and function.
    Pittman DD; Marquette KA; Kaufman RJ
    Blood; 1994 Dec; 84(12):4214-25. PubMed ID: 7994036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.